Articles tagged with Cancer Screening
A third of prostate biopsies detected cancer, with the risk increasing with each subsequent biopsy. Gene variants influencing innate immunity also linked to improved or poorer lung cancer survival in white patients. Brain tumor stem cells susceptible to a cancer-killing virus, offering new treatment hope.
Studies show that up to 50% of patients with advanced cancer suffer from major psychiatric disorders, including adjustment disorders, anxiety disorders, and depressive disorders. Effective communication, emotional support, and screening can help manage these conditions, reducing psychological distress and improving quality of life.
Existing technology and resources can solve cervical cancer's global burden, especially in developing countries. The disease disproportionately affects women worldwide, particularly in regions with limited resources.
A study found that men screened every two years had more detected cancers than those screened every four years, but aggressive cancer detection rates remained the same. The results suggest that more frequent screening may detect smaller, clinically insignificant cancers.
A multicenter study compared screening methods in high-risk women, finding that MRI accurately identifies tumors missed by mammography and ultrasound. The study suggests that women at high risk for breast cancer can benefit from undergoing screening MRI to detect more cancers.
Researchers identified promising biomarkers in urine samples, including one linked to liver and ovarian cancer. The goal is to create a simple, fast, and noninvasive test for early detection, potentially avoiding painful procedures.
Johns Hopkins scientists discovered blood-dwelling proteins CCSA-3 and CCSA-4 that accurately identify colon cancer and precancerous polyps. The researchers were 100% accurate in identifying existing cancers and correctly identified individuals with advanced precancerous polyps, suggesting a potential less invasive screening test.
Two new studies find that the uninsured and people with certain types of public health insurance are more likely to be diagnosed with more advanced cancer compared to those with private insurance. The strongest predictors of advanced disease were health insurance status and type, according to the studies published in CANCER journal.
A quadrivalent human papillomavirus (HPV) vaccine has been shown to be highly effective in preventing high-grade vulval and vaginal lesions that can lead to cancers. The vaccine reduced the risk of all high-grade vulval and vaginal lesions by 49% in a population of sexually active young women.
A new study reveals that mammography rates have declined significantly in the US between 2000 and 2005, with a notable decrease among women aged 50-64 and higher socioeconomic levels. The decline in screening rates coincides with a reduction in reported breast cancer incidence, raising concerns about potential impact on mortality rates.
A lung cancer screening regimen has been found to identify patients with early-stage cancer, allowing for curative treatment. The study suggests that annual repeat screenings can detect lung cancer at its earliest stage, resulting in a high proportion of patients having no evidence of metastases.
A new study published in Archives of Internal Medicine found that patients who received regular preventive health exams were more likely to get recommended cancer screenings. The study showed that colon cancer screenings and prostate-specific antigen tests increased by three times in the checkup group compared to those without a checkup.
Hispanics are the fastest growing minority population in the US, with socioeconomic and lifestyle differences contributing to preventable cancer deaths. A global initiative on cancer education and early detection could reduce mortality rates among this population.
A study found that computed tomography (CT) screening increased the rate of lung cancer diagnosis and treatment, but did not reduce the risk of advanced lung cancer or death. CT screening resulted in a 10-fold increase in lung cancer surgeries, which may be insufficiently beneficial to justify the morbidities.
Men who receive false-positive prostate cancer results experience heightened anxiety about their risk of developing the disease and report issues with sexual function. The study emphasizes the importance of discussing the pros and cons of screening with patients to minimize adverse effects on quality of life.
A new immunochemical fecal occult blood test (I-FOBT) shows promise in increasing colon cancer screening rates by being more accurate and convenient than traditional methods. The test uses antibodies to detect human blood in stool, eliminating dietary restrictions and allowing for personalized positivity thresholds.
A study published in Clinical Gastroenterology and Hepatology found that stool DNA testing can detect colorectal cancer with 88% accuracy, regardless of its stage or location. This non-invasive screening test offers a patient-friendly alternative to traditional colonoscopy.
A new study reveals that a specific set of symptoms and their frequency/duration can distinguish early ovarian cancer from other causes, making it a potential rapid and cost-effective screening tool. The symptom index was found to be 57% sensitive for early disease and 80% sensitive for advanced cancer.
Researchers at Indiana University School of Medicine have discovered an antibody that can differentiate between normal and altered forms of the PCNA protein in breast cancer cells, offering new hope for early detection of the disease. The discovery has also shown promise for identifying other types of cancer.
A study published in Radiology found that virtual colonoscopy is an accurate screening method for colorectal cancer. The procedure was shown to be safer, faster, less costly, more convenient, and just as effective as optical colonoscopy in detecting polyps and cancers.
A new screening tool called the pedigree assessment tool (PAT) effectively identifies women at risk for hereditary breast cancer, outperforming another commonly used tool in assessing individual patient risk. The PAT was 100% sensitive in identifying high-risk patients with potential BRCA mutations.
The study found that CAD increased cancer detection by 13.3% in screening-detected cancers and 14.2% for ductal carcinoma in situ (DCIS).CAD also improved recall rates and reduced false negatives, with the greatest impact on symptomatic patients.
A randomized controlled trial found that low-income Chinese-speaking patients were six times more likely to be screened for colorectal cancer when a clinic-based health educator provided culturally and linguistically appropriate counseling, educational materials, and screening test instructions. The intervention increased fecal occult ...
Youth-rated movies contain more images of cigarette smoking than R-rated films, with 75% of 2004 youth-rated films depicting smoking. Smoking on screen has decreased over time, but its depiction in youth-rated films remains a concern for public health.
A study found that exposure to radioactive iodine after the Chornobyl accident significantly increases the risk of thyroid cancer in children and adolescents. The researchers estimate that 75% of these cases could have been avoided without radiation exposure.
A study published in the Journal of the National Cancer Institute found that screening for lung cancer can lead to overdiagnosis, resulting in unnecessary treatment and harm. The study suggests that mass screening may not be beneficial for public health due to the potential for overdiagnosis bias.
A randomized controlled trial found that telephone support from bilingual prevention care managers significantly increased cancer screening rates among low-income and minority women. The intervention resulted in a 12% increase in mammography screenings, a 7% increase in Papanicolaou tests, and a 13% increase in colorectal screenings.
A new study provides guidelines to help doctors evaluate common test abnormalities and detect ovarian cancer with precision in asymptomatic postmenopausal women. The criteria use ultrasound and CA-125 tests to identify high-risk women, resulting in accurate detection of malignancy in over 100% of cases.
Researchers found that individuals who smoke and drink developed colon cancer an average of 7.8 years earlier than non-users, with women showing a significant gap in cancer diagnosis age compared to men. The study suggests tailoring individualized screening programs based on tobacco and alcohol consumption.
Regular screening significantly reduces cancer deaths in families with hereditary Lynch syndrome, with a 70% decrease in mortality rates. Additionally, research finds that people with IBD-related CRC have similar prognoses as the general population, while a self-propelling colonoscope shows promise in efficient and safe detection.
A recent study found that HPV infection is a top risk factor for cervical adenocarcinoma globally. The research, conducted on eight case-control studies across Africa, South America, and Southeast Asia, revealed an 80-fold increased risk of cervical adenocarcinoma among HPV-positive women.
A study published in the Journal of the American Medical Association (JAMA) found that screening for prostate cancer does not necessarily prolong survival. The research, which included over 72,000 veterans, showed that even men who received screenings were not at lower risk of death from prostate cancer.
A recent study published in the Journal of the National Cancer Institute found that screening chest x-rays can detect early-stage lung cancers at high rates. The study involved 77,465 participants and showed a significant reduction in lung cancer mortality among current smokers, with a detection rate of 6.3 cases per 1000 individuals.
African-American women who joined a cancer screening trial had better understanding of cancer and early detection, motivated by loved one's experience with cancer. The study suggests targeted strategies to improve recruitment, including providing health benefits and informing physicians about clinical trials.
Researchers seek to improve bowel cancer screening rates among socio-economically disadvantaged groups in Scotland. The study will help fill a knowledge gap on the effectiveness of primary care strategies targeting these groups.
A study found that managed care programs failed to increase colorectal cancer screening rates, with only 26% of eligible patients receiving screening. The intervention program aimed to improve screening practices but had little impact after two years.
A randomized controlled trial found that a top-down approach to promoting colorectal cancer screening in physician organizations had no effect on increasing screening rates. However, the study identified key characteristics, such as integrated medical groups and regular physical exams, which could be targeted for future interventions.
A study found that CT colonography can detect cancer lesions and polyps with nearly the same sensitivity as colonoscopy, avoiding fatal perforations but potentially leading to more cancer-related deaths. The method's higher cost is offset by its non-invasive nature and appeal to patients.
A study in New Hampshire found that many women, especially older ones, are not getting regular mammograms. The researchers used registry data to track actual use, finding 36% of women over 40 had never had a mammogram or hadn't had one in 27 months.
A study published in Cancer journal found that tumor size decreased significantly between 1975 and 1999, explaining 61% of the increased survival rate in localized breast cancer. Adjusting for tumor size diminished the magnitude of the survival increase within each stage category.
A study of 9,802 NYC residents found that nearly half are not undergoing timely screening for colon cancer, with lower uptake among African-Americans, women, and those with limited access to healthcare. The researchers emphasize the need for targeted interventions to increase screening rates in poor and uninsured communities.
A study of 1,351 deceased women and 2,501 cancer-free women found similar screening rates among both groups. Women with increased risk showed a 26% reduction in mortality, but this was not statistically significant.
The largest study to date provides valuable insights into flexible sigmoidoscopy screening among 154,942 participants aged 55-74. Findings show that women are more likely to decline FSG than men, while non-acceptance increases with age in women. The rate of cancer detected was 2.9 per 1,000 individuals screened.
A national survey found that nearly half of Americans believe misconceptions about cancer, including that surgical treatment spreads the disease. The study suggests that public education interventions are needed to address these misconceptions among vulnerable populations.
A telephone survey found that celebrity endorsements increased awareness and likelihood of certain cancer screenings, including mammography, PSA testing, and sigmoidoscopy. The study highlights the complex decision-making process around cancer screening, suggesting a need for celebrities to inform rather than persuade the public.
Researchers found that smokers receiving multiple abnormal CT scans were more likely to quit smoking and remain smoke-free. The study suggests that abnormal lung cancer screening results can serve as a psychological push for smokers to quit, leading to increased success rates.
A massive study is examining prostate cancer screening practices to determine their impact on death rates. The study follows 75,000 men, half of whom are screened and half receive conventional care, allowing researchers to compare survival rates.
Hexaminolevulinate, a fluorescence-inducing compound, enables early detection of superficial bladder cancer lesions. This increases the five-year survival rate to 90% and reduces recurrence rates.
A study of over 1.2 million mammograms found that experienced physicians detected cancer with higher accuracy and had lower rates of false positives. The research suggests that raising the minimum annual volume requirements for qualified mammographers could improve the overall quality of screening mammography in the US.
Physician experience and annual mammogram volume are associated with improved mammographic accuracy, according to a US study. Physicians who interpret 2,500-4,000 mammograms annually have lower false-positive rates and miss fewer cancers compared to those with less volume.
A new test, NMP22 tumor marker assay, has been shown to be three times more effective than a traditional laboratory test in detecting bladder cancer. The test can detect the disease in patients with blood in their urine and certain risk factors, such as smoking and exposure to chemicals.
A study of 61,688 women found that adding clinical breast examination to mammography screening detected an additional 25 cancers, but also led to false positive reports and increased biopsies in women with dense breasts
Women diagnosed with breast cancer through physical examination are more likely to undergo chemotherapy and mastectomy compared to those detected by screening mammography. The study found that cancers detected by mammography were smaller and had lower rates of lymph node spread, allowing for less-toxic treatment options.
A recent study found that false positive cancer screening test results can lead to substantial medical care costs, affecting both men and women. The research highlights the importance of considering not only the clinical benefits but also potential adverse effects of new screening tests.
A study found that African-American and Native American women had less information and more inaccurate beliefs about breast cancer screening compared to Caucasian women. Women cited pain, embarrassment, and lack of time as major reasons for not getting screened, highlighting the need for targeted interventions.
A UCLA study of 22,343 adults aged 50+ in California found that 54% had a recent CRC test, with disparities seen among Latinos, women, and those without insurance or continuity of care. Improving access to screening through policies and education programs can help address these gaps.
Dr. Jeffrey K. Springston, a UGA professor, has been awarded a $3 million grant to investigate the effectiveness of CD-ROMs versus person-to-person telephone consultations for promoting breast cancer screening. The study aims to determine which method is more cost-effective and can help increase mammography screenings among women.
The Hmong community in California is disproportionately affected by certain types of cancer, such as nasopharyngeal and liver cancer, which are often diagnosed at late stages. This is largely due to limited access to education, awareness, and screening services, highlighting the need for increased efforts to address these disparities.
A study found that late-stage breast cancer cases were often associated with an absence of screening, followed by absence of detection or a potential breakdown in follow-up care. Women from lower socioeconomic backgrounds and those without a family history of breast cancer were more likely to be in the absence-of-screening group.
A study of over 67,000 men found blacks are 35% less likely than whites to undergo PSA testing, with disparities in healthcare access and education levels potentially contributing factors